Folks with an underactive thyroid might have an elevated threat of growing small intestinal bacterial overgrowth (SIBO), a threat which may be lowered with thyroid hormone remedy, in keeping with a research being introduced Saturday at ENDO 2025, the Endocrine Society’s annual assembly in San Francisco, Calif.
We now know that individuals with hypothyroidism, particularly these with autoimmune thyroiditis, usually tend to develop SIBO, however this threat seem like mitigated in these taking thyroid medicines.”
Ruchi Mathur, M.D., Director of the Diabetes Outpatient Therapy and Schooling Heart and Director of Scientific Operations of Medically Related Science and Expertise, at Cedars-Sinai in Los Angeles, Calif.
Mathur stated their analysis additionally suggests there could also be a microbiological mechanism driving this affiliation, which might result in extra personalised therapies.
The researchers investigated the connection between SIBO and hypothyroidism in individuals older than 18 who beforehand underwent higher endoscopy with out colon prep and reported dwelling with hypothyroidism in addition to controls. Topics have been recruited by their flagship REIMAGINE research.
They analyzed small bowel fluid samples from 49 individuals with hypothyroidism and 323 with out the situation and carried out DNA sequencing to determine microbial species. The outcomes confirmed that individuals with hypothyroidism had a considerably larger prevalence of SIBO in comparison with controls (33% vs. 15%).
Mathur and colleagues then additional evaluated 4 teams: SIBO-positive with hypothyroidism, SIBO-negative with hypothyroidism, SIBO-positive with out thyroid illness, and SIBO-negative with out thyroid illness.
The evaluation confirmed completely different patterns of micro organism within the intestine relying on an individual’s thyroid standing and co-occurrence of SIBO.
Individually, they carried out a large-scale evaluation of medical data from the TriNetX database, which seemed on the 10-year dangers of growing SIBO in individuals with hypothyroidism or autoimmune thyroiditis in comparison with matched controls. The dangers have been additionally mitigated in individuals taking levothyroxine.
“Outcomes confirmed the chance of growing SIBO in topics with hypothyroidism is 2.2 instances greater than the chance in a matched management cohort and was 2.4 instances larger in these with autoimmune thyroiditis in comparison with a matched management group. This echoes our findings within the REIMAGINE cohort,” famous the research’s presenting writer, Margaret Wei, M.D., of the Cedars-Sinai Medical Heart Endocrine Fellowship Program.
“These findings open the door to new screening and prevention methods. For instance, medical doctors might start to observe thyroid well being extra carefully in sufferers with SIBO, and vice versa. It additionally helps the concept enhancing intestine well being might have far-reaching results past digestion, presumably even serving to to stop autoimmune ailments, reminiscent of Hashimoto’s,” Mathur stated. “As analysis continues, this might result in extra personalised care and earlier interventions for at-risk people.”
